Fopitasvir

福比他韦

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameFopitasvir
Drug Alias NameSKLB-HCV-79SKLB-79
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNonstructural protein 5A inhibitors
TargetsNonstructural protein 5A
Therapy Area/IndicationsHepatitis C, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSichuan UniversityChangzhou Yinsheng Pharmaceutical Co LtdChina Pharmaceutical University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSichuan UniversityChangzhou Yinsheng Pharmaceutical Co Ltd
Inactive CompaniesGinkgo Tree Pharmaceutical (Suzhou) Co Ltd
Active IndicationsHepatitis C, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A